The 3-year survival rates were 23.1% for the 76 patients with lymphatic metastasis alone, and 4.7% for the 47 patients with both lymphatic metastasis and pelvic recurrence or hematogenous metastasis.

• 单纯淋巴结转移者76例，淋巴结转移伴血道转移和／或盆腔复发者47例，3年生存率分别为23.；1%25和4